Controlled trial of acebutolol in hypertension
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF00645127.pdf
Reference13 articles.
1. Basil, B., Jordan, R., Loveless, A.H., Maxwell, D.R.: Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17, 803 A. Brit. J. Pharmacol.48, 198?211 (1973)
2. Hansson, L., Malmcrona, R., Olander, R., Rosenhall, L., Westerlund, A., Åberg, H., Hood, B.: Propranolol in hypertension. Report on 158 patients treated up to one year. Klin. Wschr.50, 364?369 (1972)
3. Hansson, L., Åberg, H., Karlberg, B.E., Westerlund, A.: Controlled study of atenolol in treatment of hypertension. Brit. med. J.1975 II, 367?370
4. Huskinsson, E.C., Wojtulewski, J.A.: Measurement of side effects of drugs. Brit. med. J.1974 II, 698?699
5. Keith, N.M., Wagener, H.P., Barker, N.W.: Some different types of essential hypertension: their course and prognosis. Amer. J. med. Sci.197, 332?340 (1939)
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis and computational studies of N-(substituted-phenyl)-4-(4-phenyl-1-piperazinyl)butanamides as potent anti-melanogenic and tyrosinase inhibitors;Journal of Molecular Structure;2020-06
2. Medications that cause weight gain and alternatives in Canada: a narrative review;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2018-08
3. Biocatalytic Approach for the Synthesis of Enantiopure Acebutolol as aβ1-Selective Blocker;Chirality;2015-05-15
4. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension;Cochrane Database of Systematic Reviews;2014-11-27
5. An efficient chiral synthesis of (R)-N-[3-acetyl-4-(2-hydroxy-3-isopropylamino-propoxy)phenyl]-butanamide with high enantioselectivity;Science in China Series B: Chemistry;2009-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3